The TASTY-training Study

Recruiting N/A Interventional Study
Oncological Patients Tyrosine Kinase Inhibitor
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
90 (estimated)
Sponsor
University Medical Center Groningen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
A multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who are randomised into different study arms. Such contact may result in bias as it may allow for patients in the control a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 and ≤70 years * Intention of being treated with tyrosine kinase inhibitors for next 12 weeks. * Experiencing taste alterations after starting treatment with tyrosine kinase inhibitors * Consuming solid foods and drinks is possible * ≤50% of recommended daily intake in …
Contacts

J. J.A. de Haan, MD, PhD

+31 50 361 2821

j.j.de.haan@umcg.nl

CONTACT

M. D. Douma

+31 50 361 4603

m.d.douma@umcg.nl

CONTACT